Global Immuno-oncology Drugs Market Insights and Forecast to 2028

Global Immuno-oncology Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Immuno-oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Oncolytic Virus
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Immuno-oncology Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Immuno-oncology Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Immuno-oncology Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Immuno-oncology Drugs Sales by Region
2.4.1 Global Immuno-oncology Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Immuno-oncology Drugs by Region (2023-2028)
2.5 Global Immuno-oncology Drugs Revenue by Region
2.5.1 Global Immuno-oncology Drugs Revenue by Region (2017-2022)
2.5.2 Global Immuno-oncology Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Immuno-oncology Drugs Sales by Manufacturers
3.1.1 Global Top Immuno-oncology Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immuno-oncology Drugs in 2021
3.2 Global Immuno-oncology Drugs Revenue by Manufacturers
3.2.1 Global Immuno-oncology Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Immuno-oncology Drugs Revenue in 2021
3.3 Global Immuno-oncology Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Immuno-oncology Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immuno-oncology Drugs Sales by Type
4.1.1 Global Immuno-oncology Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Immuno-oncology Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
4.2 Global Immuno-oncology Drugs Revenue by Type
4.2.1 Global Immuno-oncology Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Immuno-oncology Drugs Price by Type
4.3.1 Global Immuno-oncology Drugs Price by Type (2017-2022)
4.3.2 Global Immuno-oncology Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Immuno-oncology Drugs Sales by Application
5.1.1 Global Immuno-oncology Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Immuno-oncology Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
5.2 Global Immuno-oncology Drugs Revenue by Application
5.2.1 Global Immuno-oncology Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Immuno-oncology Drugs Price by Application
5.3.1 Global Immuno-oncology Drugs Price by Application (2017-2022)
5.3.2 Global Immuno-oncology Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Immuno-oncology Drugs Market Size by Type
6.1.1 North America Immuno-oncology Drugs Sales by Type (2017-2028)
6.1.2 North America Immuno-oncology Drugs Revenue by Type (2017-2028)
6.2 North America Immuno-oncology Drugs Market Size by Application
6.2.1 North America Immuno-oncology Drugs Sales by Application (2017-2028)
6.2.2 North America Immuno-oncology Drugs Revenue by Application (2017-2028)
6.3 North America Immuno-oncology Drugs Market Size by Country
6.3.1 North America Immuno-oncology Drugs Sales by Country (2017-2028)
6.3.2 North America Immuno-oncology Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Immuno-oncology Drugs Market Size by Type
7.1.1 Europe Immuno-oncology Drugs Sales by Type (2017-2028)
7.1.2 Europe Immuno-oncology Drugs Revenue by Type (2017-2028)
7.2 Europe Immuno-oncology Drugs Market Size by Application
7.2.1 Europe Immuno-oncology Drugs Sales by Application (2017-2028)
7.2.2 Europe Immuno-oncology Drugs Revenue by Application (2017-2028)
7.3 Europe Immuno-oncology Drugs Market Size by Country
7.3.1 Europe Immuno-oncology Drugs Sales by Country (2017-2028)
7.3.2 Europe Immuno-oncology Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immuno-oncology Drugs Market Size by Type
8.1.1 Asia Pacific Immuno-oncology Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Immuno-oncology Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Immuno-oncology Drugs Market Size by Application
8.2.1 Asia Pacific Immuno-oncology Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Immuno-oncology Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Immuno-oncology Drugs Market Size by Region
8.3.1 Asia Pacific Immuno-oncology Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Immuno-oncology Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Immuno-oncology Drugs Market Size by Type
9.1.1 Latin America Immuno-oncology Drugs Sales by Type (2017-2028)
9.1.2 Latin America Immuno-oncology Drugs Revenue by Type (2017-2028)
9.2 Latin America Immuno-oncology Drugs Market Size by Application
9.2.1 Latin America Immuno-oncology Drugs Sales by Application (2017-2028)
9.2.2 Latin America Immuno-oncology Drugs Revenue by Application (2017-2028)
9.3 Latin America Immuno-oncology Drugs Market Size by Country
9.3.1 Latin America Immuno-oncology Drugs Sales by Country (2017-2028)
9.3.2 Latin America Immuno-oncology Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immuno-oncology Drugs Market Size by Type
10.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Immuno-oncology Drugs Market Size by Application
10.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Immuno-oncology Drugs Market Size by Country
10.3.1 Middle East and Africa Immuno-oncology Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Immuno-oncology Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen, Inc
11.1.1 Amgen, Inc Corporation Information
11.1.2 Amgen, Inc Overview
11.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen, Inc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen, Inc Recent Developments
11.2 AstraZeneca, Plc
11.2.1 AstraZeneca, Plc Corporation Information
11.2.2 AstraZeneca, Plc Overview
11.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca, Plc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca, Plc Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Corporation Information
11.4.2 Celgene Corporation Overview
11.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Celgene Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Celgene Corporation Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Corporation Information
11.6.2 Merck & Co. Overview
11.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck & Co. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co. Recent Developments
11.7 Hoffmann-La Roche AG
11.7.1 Hoffmann-La Roche AG Corporation Information
11.7.2 Hoffmann-La Roche AG Overview
11.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hoffmann-La Roche AG Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Novartis International AG
11.9.1 Novartis International AG Corporation Information
11.9.2 Novartis International AG Overview
11.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis International AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis International AG Recent Developments
11.10 AbbVie, Inc.
11.10.1 AbbVie, Inc. Corporation Information
11.10.2 AbbVie, Inc. Overview
11.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AbbVie, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie, Inc. Recent Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Corporation Information
11.11.2 Pfizer Inc. Overview
11.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfizer Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Inc. Recent Developments
11.12 Sanofi S.A.
11.12.1 Sanofi S.A. Corporation Information
11.12.2 Sanofi S.A. Overview
11.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Sanofi S.A. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sanofi S.A. Recent Developments
11.13 EMD Serono, Inc.
11.13.1 EMD Serono, Inc. Corporation Information
11.13.2 EMD Serono, Inc. Overview
11.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 EMD Serono, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 EMD Serono, Inc. Recent Developments
11.14 Gilead Sciences Inc.
11.14.1 Gilead Sciences Inc. Corporation Information
11.14.2 Gilead Sciences Inc. Overview
11.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Gilead Sciences Inc. Recent Developments
11.15 Prometheus Therapeutics & Diagnostics
11.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
11.15.2 Prometheus Therapeutics & Diagnostics Overview
11.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Prometheus Therapeutics & Diagnostics Recent Developments
11.16 Aduro BioTech
11.16.1 Aduro BioTech Corporation Information
11.16.2 Aduro BioTech Overview
11.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Aduro BioTech Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Aduro BioTech Recent Developments
11.17 Galena Biopharma
11.17.1 Galena Biopharma Corporation Information
11.17.2 Galena Biopharma Overview
11.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Galena Biopharma Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Galena Biopharma Recent Developments
11.18 Bavarian Nordic
11.18.1 Bavarian Nordic Corporation Information
11.18.2 Bavarian Nordic Overview
11.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Bavarian Nordic Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Bavarian Nordic Recent Developments
11.19 Celldex Therapeutics
11.19.1 Celldex Therapeutics Corporation Information
11.19.2 Celldex Therapeutics Overview
11.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Celldex Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Celldex Therapeutics Recent Developments
11.20 ImmunoCellular Therapeutics
11.20.1 ImmunoCellular Therapeutics Corporation Information
11.20.2 ImmunoCellular Therapeutics Overview
11.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 ImmunoCellular Therapeutics Recent Developments
11.21 Incyte
11.21.1 Incyte Corporation Information
11.21.2 Incyte Overview
11.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Incyte Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Incyte Recent Developments
11.22 Dendreon Corporation
11.22.1 Dendreon Corporation Corporation Information
11.22.2 Dendreon Corporation Overview
11.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Dendreon Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Dendreon Corporation Recent Developments
11.23 Agilent Technologies Inc.
11.23.1 Agilent Technologies Inc. Corporation Information
11.23.2 Agilent Technologies Inc. Overview
11.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Agilent Technologies Inc. Recent Developments
11.24 Agenus Inc.
11.24.1 Agenus Inc. Corporation Information
11.24.2 Agenus Inc. Overview
11.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Agenus Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Agenus Inc. Recent Developments
11.25 Enzo Biochem, Inc.
11.25.1 Enzo Biochem, Inc. Corporation Information
11.25.2 Enzo Biochem, Inc. Overview
11.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Enzo Biochem, Inc. Recent Developments
11.26 Lonza Group
11.26.1 Lonza Group Corporation Information
11.26.2 Lonza Group Overview
11.26.3 Lonza Group Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Lonza Group Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Lonza Group Recent Developments
11.27 Bio-Rad Laboratories, Inc.
11.27.1 Bio-Rad Laboratories, Inc. Corporation Information
11.27.2 Bio-Rad Laboratories, Inc. Overview
11.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Bio-Rad Laboratories, Inc. Recent Developments
11.28 Avantor, Inc.
11.28.1 Avantor, Inc. Corporation Information
11.28.2 Avantor, Inc. Overview
11.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Avantor, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Avantor, Inc. Recent Developments
11.29 Spring Bank Pharmaceuticals, Inc.
11.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
11.29.2 Spring Bank Pharmaceuticals, Inc. Overview
11.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments
11.30 Ferring Pharmaceuticals
11.30.1 Ferring Pharmaceuticals Corporation Information
11.30.2 Ferring Pharmaceuticals Overview
11.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Ferring Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immuno-oncology Drugs Industry Chain Analysis
12.2 Immuno-oncology Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immuno-oncology Drugs Production Mode & Process
12.4 Immuno-oncology Drugs Sales and Marketing
12.4.1 Immuno-oncology Drugs Sales Channels
12.4.2 Immuno-oncology Drugs Distributors
12.5 Immuno-oncology Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Immuno-oncology Drugs Industry Trends
13.2 Immuno-oncology Drugs Market Drivers
13.3 Immuno-oncology Drugs Market Challenges
13.4 Immuno-oncology Drugs Market Restraints
14 Key Findings in The Global Immuno-oncology Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Immuno-oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Immune Checkpoint Inhibitors
Table 3. Major Manufacturers of Immune System Modulators
Table 4. Major Manufacturers of Cancer Vaccines
Table 5. Major Manufacturers of Oncolytic Virus
Table 6. Major Manufacturers of Others
Table 7. Global Immuno-oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Immuno-oncology Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Immuno-oncology Drugs Sales by Region (2017-2022) & (K Units)
Table 10. Global Immuno-oncology Drugs Sales Market Share by Region (2017-2022)
Table 11. Global Immuno-oncology Drugs Sales by Region (2023-2028) & (K Units)
Table 12. Global Immuno-oncology Drugs Sales Market Share by Region (2023-2028)
Table 13. Global Immuno-oncology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Immuno-oncology Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global Immuno-oncology Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Immuno-oncology Drugs Revenue Market Share by Region (2023-2028)
Table 17. Global Immuno-oncology Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Immuno-oncology Drugs Sales Share by Manufacturers (2017-2022)
Table 19. Global Immuno-oncology Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Immuno-oncology Drugs Revenue Share by Manufacturers (2017-2022)
Table 21. Immuno-oncology Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2021)
Table 24. Immuno-oncology Drugs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Immuno-oncology Drugs Product Offered
Table 26. Date of Manufacturers Enter into Immuno-oncology Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 29. Global Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 30. Global Immuno-oncology Drugs Sales Share by Type (2017-2022)
Table 31. Global Immuno-oncology Drugs Sales Share by Type (2023-2028)
Table 32. Global Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Immuno-oncology Drugs Revenue Share by Type (2017-2022)
Table 35. Global Immuno-oncology Drugs Revenue Share by Type (2023-2028)
Table 36. Immuno-oncology Drugs Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Immuno-oncology Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 39. Global Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 40. Global Immuno-oncology Drugs Sales Share by Application (2017-2022)
Table 41. Global Immuno-oncology Drugs Sales Share by Application (2023-2028)
Table 42. Global Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Immuno-oncology Drugs Revenue Share by Application (2017-2022)
Table 45. Global Immuno-oncology Drugs Revenue Share by Application (2023-2028)
Table 46. Immuno-oncology Drugs Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Immuno-oncology Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 49. North America Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 50. North America Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 53. North America Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 54. North America Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
Table 57. North America Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
Table 58. North America Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 61. Europe Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 62. Europe Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Europe Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
Table 69. Europe Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
Table 70. Europe Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Immuno-oncology Drugs Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Immuno-oncology Drugs Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Immuno-oncology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Immuno-oncology Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Amgen, Inc Corporation Information
Table 109. Amgen, Inc Description and Major Businesses
Table 110. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Amgen, Inc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Amgen, Inc Recent Developments
Table 113. AstraZeneca, Plc Corporation Information
Table 114. AstraZeneca, Plc Description and Major Businesses
Table 115. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. AstraZeneca, Plc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca, Plc Recent Developments
Table 118. Bristol-Myers Squibb Corporation Information
Table 119. Bristol-Myers Squibb Description and Major Businesses
Table 120. Bristol-Myers Squibb Immuno-oncol

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs